Findings from one of the largest HIV/AIDS therapy studies conducted to date show that a specific strategy of interrupting antiretroviral therapy more than doubles the risk of AIDS or death from any cause.
Mayo Clinic Cancer Center has begun three clinical studies looking at the use of nonsteroidal anti-inflammatory drugs (NSAIDs) to prevent cancer — colon, esophageal or lung.
Researchers at Harvard Medical School’s Brigham and Women’s Hospital compared the effects of a variety of immunosuppressive agents on cardiovascular events in a large sample of RA patients.
With flu-shot season in full swing and widespread anticipation of the HPV vaccine to prevent cervical cancer, a new University of Rochester study suggests that using common painkillers around the time of vaccination might not be a good idea.
For patients on hemodialysis, the use of dialysis filters coated with vitamin E may provide a simple new approach to the common problem of anemia, reports a paper presented at the American Society of Nephrology’s 39th Annual Meeting and Scientific Exposition in San Diego.
New research at Wake Forest University School of Medicine suggests that certain inhaled asthma medications ? as well as similar chemicals our bodies produce during times of high stress ? may worsen diseases such as asthma, heart failure and lupus that involve inflammation.
New research at Wake Forest University School of Medicine suggests that certain inhaled asthma medications — as well as similar chemicals our bodies produce during times of high stress — may worsen diseases such as asthma, heart failure and lupus that involve inflammation.
There is no evidence antibiotics help the vast majority of patients with acute bronchitis, and doctors should stop routinely prescribing them, researchers reported on Wednesday.
In two studies presented during the annual meeting of the American College of Allergy, Asthma and Immunology (ACAAI), held in Philadelphia November 9-15, caregivers considered the ?seal of approval? from the FDA to be the most important factor when looking for an effective asthma treatment for their child. Caregivers and physicians also expressed in the study the need for a standardized assessment tool that could help diagnose and monitor asthma.
Children treated with PULMICORT RESPULES? (budesonide inhalation suspension) either once or twice daily experienced a significantly greater increase in the percentage of asthma-control days compared to those receiving placebo. These results are being presented at the annual meeting of the American College of Allergy, Asthma and Immunology (ACAAI), held in Philadelphia on November 9-15. Asthma-control days were defined as days when children were free of symptoms and did not use rescue medications during the day and night. Control of asthma symptoms during the day and night and reduction of the need for rescue medication is an important goal of asthma therapy in keeping with current National Asthma Education and Prevention Program (NAEPP) guidelines.